Acute kidney injury, which occurs when a person's kidney function deteriorates over a short period of time, can have severe health consequences, including end stage kidney disease and even premature death. AKI is increasingly common and occurs in approximately 1.6% of all hospitalizations in the United States. It is also a common complication that arises in individuals who are hospitalized for other causes.

Although many cases of AKI may be an inevitable result of severe illness, some cases may be preventable by adjusting medication doses or limiting the use of intravenous contrast agents, which are commonly used to improve the visibility of internal bodily structures. To avoid the potential after effects of AKI, researchers are interested in identifying individuals at increased risk for AKI and preventing the initial damage to the kidneys.

Morgan Grams, MD, Josef Coresh, MD, PhD, and their colleagues at Johns Hopkins University studied risk factors for AKI in the general population. Using information from a large population-based group of 11,200 individuals who were followed for an average of eight years, the investigators evaluated the potential links between acute kidney injury and markers of reduced kidney function (estimated glomerular filtration rate, or eGFR) and kidney damage (protein excreted in the urine, or albuminuria), as well as traditionally recognized risk factors, such as age, race, and sex.

Dr. Grams, Dr. Coresh, and their team discovered that patients with the highest levels of albuminuria had almost a 5-fold increased risk of developing AKI. Similarly, the risk of developing acute kidney injury increased, as eGFR decreased. These associations persisted within subgroups of patients categorized by age, race, and sex. "The results suggest that a person's risk profile for acute kidney injury depends not only on eGFR, which is the basis of the current kidney disease staging system, but also on levels of albuminuria," said Dr. Grams, the lead author on the paper. The authors noted that as strategies for AKI prevention are developed, preventative measures should be considered for patients both with albuminuria and decreased eGFR.

Study co-authors include Brad Astor, PhD (Johns Hopkins University School of Medicine and Johns Hopkins Bloomberg School of Public Health), Lori Bash, PhD, Kunihiro Matsushita, MD, PhD, and Yaping Wang (Johns Hopkins Bloomberg School of Public Health).

Note: If no author is given, the source is cited instead.

• Kidney Disease
• Asthma
• Urology
• Diseases and Conditions
• Teen Health
• Healthy Aging

• Excretory system
• Kidney transplantation
• Dialysis
• Inflammation of the kidney
• Kidney stone
• Transplant rejection